GMO Pepabo Inc
TSE:3633
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
GMO Pepabo Inc
TSE:3633
|
JP |
|
T
|
Totm Technologies Ltd
SGX:42F
|
SG |
|
P
|
Pontus Protein Ltd
XTSX:HULK
|
CA |
|
P
|
Petrus Resources Ltd
TSX:PRQ
|
CA |
|
E
|
Ecomate Holdings Bhd
KLSE:ECOMATE
|
MY |
|
P
|
Prodigy PCL
SET:PDG
|
TH |
|
Intellia Therapeutics Inc
NASDAQ:NTLA
|
US |
|
Otrs AG
F:TR9
|
DE |
|
D
|
Digitalist Group Oyj
OMXH:DIGIGR
|
FI |
|
Silex Systems Ltd
ASX:SLX
|
AU |
|
Kopore Metals Ltd
ASX:KMT
|
AU |
|
E
|
Emerson Electric Co
BMV:EMR
|
US |
|
V
|
Vonovia SE
LSE:0QFT
|
DE |
|
Hartshead Resources NL
ASX:HHR
|
AU |
|
D
|
Datalex PLC
ISEQ:DLE
|
IE |
|
Comsys Holdings Corp
TSE:1721
|
JP |
|
S
|
Sun-Wa Technos Corp
TSE:8137
|
JP |
|
Deterra Royalties Ltd
ASX:DRR
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GMO Pepabo Inc's stock price target?
Not Available
GMO Pepabo Inc doesn't have any price targets made by Wall Street professionals.
What is GMO Pepabo Inc's Revenue forecast?
Projected CAGR
0%
For the last 13 years the
compound annual growth rate for
GMO Pepabo Inc's revenue is
9%.
The projected
CAGR
for the next 2 years is
0%.
What is GMO Pepabo Inc's Net Income forecast?
Projected CAGR
12%
For the last 13 years the
compound annual growth rate for
GMO Pepabo Inc's net income is
3%.
The projected
CAGR
for the next 2 years is
12%.